These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10639635)

  • 1. Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense.
    Brieger D; Topol E
    J Thromb Thrombolysis; 1997; 4(3/4):325-327. PubMed ID: 10639635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
    French JK; Edmond JJ; Gao W; White HD; Eikelboom JW
    Am J Cardiovasc Drugs; 2004; 4(2):107-15. PubMed ID: 15049722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.
    Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators
    N Engl J Med; 1996 Sep; 335(11):775-82. PubMed ID: 8778585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
    Metz BK; White HD; Granger CB; Simes RJ; Armstrong PW; Hirsh J; Fuster V; MacAulay CM; Califf RM; Topol EJ
    J Am Coll Cardiol; 1998 Jun; 31(7):1493-8. PubMed ID: 9626825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
    Carswell CI; Plosker GL
    Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desirudin: a review of its use in the management of thrombotic disorders.
    Matheson AJ; Goa KL
    Drugs; 2000 Sep; 60(3):679-700. PubMed ID: 11030473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant hirudins: an overview of recent developments.
    Zeymer U
    BioDrugs; 1998 Dec; 10(6):425-36. PubMed ID: 18020612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TIMI 9b and GUSTO IIb Trials and the "Thrombin Hypothesis".
    Andreotti F
    J Thromb Thrombolysis; 1997; 4(3/4):311-313. PubMed ID: 10639631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
    Direct Thrombin Inhibitor Trialists' Collaborative Group
    Lancet; 2002 Jan; 359(9303):294-302. PubMed ID: 11830196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hirudin in Acute Myocardial Infarction.
    Cannon CP
    J Thromb Thrombolysis; 1995; 1(3):259-267. PubMed ID: 10608003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hirudin in acute coronary syndromes.
    van de Loo A; Bode C
    Semin Thromb Hemost; 2002 Oct; 28(5):459-66. PubMed ID: 12420242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty.
    Cannon CP; Braunwald E
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):30S-37S. PubMed ID: 7775712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
    Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.
    Antman EM
    Circulation; 1994 Oct; 90(4):1624-30. PubMed ID: 7923644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) study and the results in the context of other trials.
    Fox KA
    Am J Cardiol; 1999 Sep; 84(5A):26M-31M. PubMed ID: 10505540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.
    Bahit MC; Topol EJ; Califf RM; Armstrong PW; Criger DA; Hasselblad V; Betriu A; Hirsh J; Ardissino D; Granger CB
    J Am Coll Cardiol; 2001 Mar; 37(4):1001-7. PubMed ID: 11263599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
    Topol EJ; Fuster V; Harrington RA; Califf RM; Kleiman NS; Kereiakes DJ; Cohen M; Chapekis A; Gold HK; Tannenbaum MA
    Circulation; 1994 Apr; 89(4):1557-66. PubMed ID: 8149521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to the treatment of unstable angina and non-Q wave myocardial infarction.
    Cohen M
    Can J Cardiol; 1998 Aug; 14 Suppl E():11E-14E. PubMed ID: 9779027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.
    Antman EM
    Circulation; 1996 Sep; 94(5):911-21. PubMed ID: 8790025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulants in acute coronary syndromes.
    Turpie AG
    Am J Cardiol; 1999 Sep; 84(5A):2M-6M. PubMed ID: 10505536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.